Matrix Capital Management Company, LP - Q1 2021 holdings

$8.66 Billion is the total value of Matrix Capital Management Company, LP's 30 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 66.7% .

 Value Shares↓ Weighting
ADPT SellADAPTIVE BIOTECHNOLOGIES COR$495,564,000
-36.1%
12,309,090
-6.1%
5.72%
-31.8%
MU SellMICRON TECHNOLOGY INC$310,180,000
-48.3%
3,516,380
-56.0%
3.58%
-44.8%
SILK SellSILK RD MED INC$27,285,000
-48.9%
538,700
-36.4%
0.32%
-45.4%
ABCL ExitABCELLERA BIOLOGICS INC$0-250,000
-100.0%
-0.11%
AI ExitC3 AI INCcl a$0-300,000
-100.0%
-0.45%
SPLK ExitSPLUNK INC$0-300,000
-100.0%
-0.55%
GWRE ExitGUIDEWIRE SOFTWARE INC$0-400,000
-100.0%
-0.56%
U ExitUNITY SOFTWARE INC$0-500,000
-100.0%
-0.83%
DOCU ExitDOCUSIGN INC$0-1,345,166
-100.0%
-3.23%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-17
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TRANSDIGM GROUP INC42Q3 202313.3%
WORKDAY INC42Q3 202319.7%
NETFLIX INC37Q2 202226.1%
NEW RELIC INC29Q1 20227.8%
DAVITA INC26Q3 20196.1%
ADAPTIMMUNE THERAPEUTICS PLC26Q3 20236.8%
SALESFORCE INC23Q3 202218.4%
CONSTELLATION BRANDS INC23Q2 20195.7%
AMAZON COM INC21Q3 202311.2%
TABLEAU SOFTWARE INC20Q2 201915.2%

View Matrix Capital Management Company, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Matrix Capital Management Company, LP Q1 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Adaptimmune Therapeutics PLCJuly 10, 2023233,845,11017.3%
Zentalis Pharmaceuticals, Inc.June 20, 202313,959,97319.8%
ForgeRock, Inc.Sold outFebruary 13, 202300.0%
NEW RELIC, INC.Sold outFebruary 13, 202300.0%
Perimeter Solutions, SAFebruary 13, 20238,587,5005.4%
Aura Biosciences, Inc.December 07, 20225,362,87014.5%
Adaptive Biotechnologies CorpFebruary 14, 202211,572,5908.2%
BigCommerce Holdings, Inc.Sold outFebruary 14, 202200.0%
CarGurus, Inc.Sold outFebruary 16, 202100.0%
Trillium Therapeutics Inc.Sold outFebruary 14, 202000.0%

View Matrix Capital Management Company, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
SC 13G/A2024-02-13
13F-HR2023-11-14
42023-11-09
SC 13D/A2023-11-09
13F-HR2023-08-14
SC 13G/A2023-07-10
42023-06-20
SC 13D/A2023-06-20
13F-HR2023-05-15

View Matrix Capital Management Company, LP's complete filings history.

Compare quarters

Export Matrix Capital Management Company, LP's holdings